100s of titles, one news app for just $10 a month.
Dive Deeper:
CytoSorbents's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, CytoSorbents's (NASDAQ:CTSO) reported sales totaled $8.69 million. Despite a 3.66% increase in…
Workiva's Return On Capital Employed Insights
Benzinga Pro data, Workiva (NYSE:WK) reported Q1 sales of $129.67 million. Earnings fell to a loss of $18.49 million, resulting…
MPLX's Return On Capital Employed Insights
Pulled from Benzinga Pro data, MPLX (NYSE:MPLX) posted Q1 earnings of $833.00 million, an increase from Q4 of 0.6%. Sales…
Triton International's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Triton International (NYSE:TRTN) posted Q1 earnings of $194.26 million, an increase from Q4 of 2.0%.…
One subscription that gives you access to news from hundreds of sites
Kymera Therapeutics's Return On Capital Employed Insights
Benzinga Pro data, Kymera Therapeutics (NASDAQ:KYMR) reported Q1 sales of $9.62 million. Earnings fell to a loss of $36.68 million,…
Apollo Endosurgery's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Apollo Endosurgery's (NASDAQ:APEN) reported sales totaled $16.66 million. Despite a 19.14% increase…
Get all your news in one place
Latest Business news:
Bitcoin Recovers After Longest Run of Weekly Losses Since 2011
Bitcoin recovered to trade just above the $30,000 level where it’s been mostly hovering since the collapse of the TerraUSD…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
How to Make Money (or Even Get Rich) During a Stock Market Crash
A crash creates buying opportunities if you can develop the right mindset.
HSBC suspends head of responsible investing who called climate warnings ‘shrill’
Bank investigating Stuart Kirk’s conference speech deriding flooding risks and climate warnings from UN and Bank of England
Former NAB manager quizzed on Star scheme
A former NAB employee has told an inquiry into Star Entertainment Group's Sydney casino he had no knowledge of a…
After $5 Trillion Rout, Emerging Markets Seek Turnaround Signal
The wreckage of a $5 trillion rout in emerging markets is starting to look like a buying opportunity to some…
From analysis to good news, read the world’s best news in one place
New Zealand PM Ardern to visit U.S. to boost exports, lure tourists
New Zealand Prime Minister Jacinda Ardern will visit the United States this week in a bid to boost exports and…
Rod Sims says Facebook should be forced to negotiate with SBS under news media bargaining code
Despite dozens of deals to pay Australian news publishers for content, social media company has left out SBS and the…

Mercury General's Return On Capital Employed Insights

By Benzinga Insights

Mercury General (NYSE:MCY) brought in sales totaling $805.46 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 746.2%, resulting in a loss of $196.92 million. Mercury General earned $30.47 million, and sales totaled $994.57 million in Q4.

Why Is ROCE Significant?

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q1, Mercury General posted an ROCE of -0.1%.

It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Mercury General is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Mercury General, a negative ROCE ratio of -0.1% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Upcoming Earnings Estimate

Mercury General reported Q1 earnings per share at $-0.77/share, which did not meet analyst predictions of $0.65/share.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
CytoSorbents's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, CytoSorbents's (NASDAQ:CTSO) reported sales totaled $8.69 million. Despite a 3.66% increase in…
Workiva's Return On Capital Employed Insights
Benzinga Pro data, Workiva (NYSE:WK) reported Q1 sales of $129.67 million. Earnings fell to a loss of $18.49 million, resulting…
MPLX's Return On Capital Employed Insights
Pulled from Benzinga Pro data, MPLX (NYSE:MPLX) posted Q1 earnings of $833.00 million, an increase from Q4 of 0.6%. Sales…
Triton International's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Triton International (NYSE:TRTN) posted Q1 earnings of $194.26 million, an increase from Q4 of 2.0%.…
One subscription that gives you access to news from hundreds of sites
Kymera Therapeutics's Return On Capital Employed Insights
Benzinga Pro data, Kymera Therapeutics (NASDAQ:KYMR) reported Q1 sales of $9.62 million. Earnings fell to a loss of $36.68 million,…
Apollo Endosurgery's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Apollo Endosurgery's (NASDAQ:APEN) reported sales totaled $16.66 million. Despite a 19.14% increase…
Get all your news in one place